Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

11.4 Event 201 #47

Open
mukeshp70 opened this issue May 15, 2020 · 3 comments
Open

11.4 Event 201 #47

mukeshp70 opened this issue May 15, 2020 · 3 comments

Comments

@mukeshp70
Copy link

In continuation under 11.4.........
To the best of our knowledge, no measure were taken to hide the existence of Event 201 from the public.........

But are we aware about China conducted National Public Health Emergency Response Drill in July 2019 ????
The answer is no, because CCP (China) didn't want that the world should know the truth........

The National Health Commission held the 2019 National Public Health Emergency Response Drill
Release time: 2019-07-25 Source: Health Emergency Office

On July 25, the National Health Commission held the 2019 National Public Health Emergency Response Drill. Yu Xuejun, deputy director of the National Health Commission, Yang Peijun,
deputy chairman of the Ningxia Hui Autonomous Region Government, and Ma Xiuzhen, vice chairman of the CPPCC National Committee and director of the health committee
attended the drill.

This exercise is a comprehensive exercise for the prevention and control of imported sudden acute infectious diseases. Based on the background of an X virus disease import epidemic discovered in Ningxia and the local epidemic of X virus disease in a province,case detection and early disposal, case report, transshipment and admission, epidemiological investigation, specimen collection and inspection, and epidemic confirmation and release were set up , Case treatment, termination of response, etc.

The exercise adopts a nationwide synchronous video connection. More than 8,200 people from
various provinces and some cities, county-level health committees and related departments participated in the exercise. The exercise combines the theme education of “not forgetting the original intention and remembering the mission”. Starting from preventing and resolving major risks, the design scenario is close to reality, the organization is well organized, and the national
communication and interaction are full. It reflects the achievements of the national health emergency system and capacity building in recent years.

The drill was co-sponsored by the National Health Commission and the Ningxia Hui Autonomous Region Government. Representatives from the Ministry of Public Security, the Ministry of Communications, the Ministry of Emergency Response, the General Administration of Customs, the Immigration Bureau, the Civil Aviation Administration, Hong Kong and Macau Health
Departments, and WHO representatives participated in the exercise.

Did WHO representatives are also the part of the syndicate...............

The same may be accessed at:
http://www.nhc.gov.cn/yjb/s3578/201907/02712ed2e9694fa9824d869c1c4517a5.shtml
Archived at: https://archive.is/wip/pZU9b

@mukeshp70
Copy link
Author

Does the Gilead, US Company know, CCP applied for patent of "Remdesivir" for new coronavirus????

Wuhan Virus Research Ownership squat “Remdesivir” use patent, but the problem is ...

The "Remdesivir", which may have special effects on the treatment of new pneumonia , was registered by the Wuhan Virus Research Institute for the invention patent!

For the drug Remdesivir, which has not been marketed in China and has intellectual property rights barriers, we applied for a Chinese invention patent on January 21 from the perspective of protecting national interests (use of anti-2019 new coronavirus) according to international practice , And will enter the major countries in the world through the PCT (Patent Cooperation Agreement).

The drug was originally used as a test drug for Ebola virus, which has a strong anti-filament virus effect in vitro, and has completed a phase III clinical trial.

The drug researcher and development company Gilead repeatedly emphasized that the drug is still in the research stage. No country is officially listed. Therefore, Gilead did not apply for a patent for the use of this drug against the new coronavirus, but it was preempted by the Wuhan Virus Research Institute.

But the question is, the R & D side of the drug is not sure whether the drug can resist the new coronavirus. Where can the Wuhan Virus Research Institute be sure? It also generously declared that "the rights claimed by the patent are not yet implemented."

Wuhan Virus Research Institute does not conduct experiments in humans, and there is no detailed human test data. The data are only validated by cells in vitro.

Indeed, the Wuhan Virus Research Institute should make a reasonable explanation for this. After all, the drug is currently very important. After all, the drug was developed by the American Gilead company at a huge cost .
Can be assessed at: http://wechatscope.jmsc.hku.hk:8000/html?fn=gh_0908bc7f934f_2020-02-05_2247486719_52jlKcECOX.y.tar.gz
Archived at: http://archive.is/nZStf

@mukeshp70
Copy link
Author

On September 18, 2019, Wuhan Tianhe Airport conducted a new coronavirus infection drill
http://bbs.creaders.net/life/bbsviewer.php?btrd_id=5367211&btrd_trd_id=1451
Archived at: http://archive.is/wip/fy6KO
Translated version: Wuhan Tianhe Airport conducted a new coronavirus infection drill.pdf

@mukeshp70
Copy link
Author

Weibo message:
Drill.pdf

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

1 participant